The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes
Public ClinicalTrials.gov record NCT01836523. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes. A 52-week Randomised, Treat-to-target, Placebo-controlled, Double Blinded, Parallel Group, Multinational, Multi-centre Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted globally. The aim of the trial is to confirm the efficacy and safety of liraglutide as adjunct therapy to insulin in the treatment of type 1 diabetes. The total trial duration per subject is approximately 58 weeks.
Study identification
- NCT ID
- NCT01836523
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,398 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2013 (Type not available)
- Primary completion
- Jun 2015 (Actual)
- Completion
- Jun 2015 (Actual)
- Last update posted
- Mar 6, 2017
2013 – 2015
United States locations
- U.S. sites
- 70
- U.S. states
- 27
- U.S. cities
- 63
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Little Rock | Arkansas | 72205 | — |
| Novo Nordisk Investigational Site | Concord | California | 94520 | — |
| Novo Nordisk Investigational Site | Encino | California | 91436 | — |
| Novo Nordisk Investigational Site | Escondido | California | 92025 | — |
| Novo Nordisk Investigational Site | Huntington Beach | California | 92648 | — |
| Novo Nordisk Investigational Site | La Mesa | California | 91942 | — |
| Novo Nordisk Investigational Site | Lancaster | California | 93534 | — |
| Novo Nordisk Investigational Site | Monterey | California | 93940 | — |
| Novo Nordisk Investigational Site | San Mateo | California | 94401 | — |
| Novo Nordisk Investigational Site | San Ramon | California | 94583 | — |
| Novo Nordisk Investigational Site | Walnut Creek | California | 94598 | — |
| Novo Nordisk Investigational Site | Denver | Colorado | 80209 | — |
| Novo Nordisk Investigational Site | Fort Lauderdale | Florida | 33312 | — |
| Novo Nordisk Investigational Site | Hialeah | Florida | 33012 | — |
| Novo Nordisk Investigational Site | Jacksonville | Florida | 32258 | — |
| Novo Nordisk Investigational Site | Tampa | Florida | 33619 | — |
| Novo Nordisk Investigational Site | Atlanta | Georgia | 30308-2253 | — |
| Novo Nordisk Investigational Site | Atlanta | Georgia | 30318 | — |
| Novo Nordisk Investigational Site | Marietta | Georgia | 30060 | — |
| Novo Nordisk Investigational Site | Roswell | Georgia | 30076 | — |
| Novo Nordisk Investigational Site | Savannah | Georgia | 31405 | — |
| Novo Nordisk Investigational Site | Idaho Falls | Idaho | 83404-7596 | — |
| Novo Nordisk Investigational Site | Indianapolis | Indiana | 46254 | — |
| Novo Nordisk Investigational Site | Council Bluffs | Iowa | 51501 | — |
| Novo Nordisk Investigational Site | Iowa City | Iowa | 52242 | — |
| Novo Nordisk Investigational Site | Topeka | Kansas | 66606 | — |
| Novo Nordisk Investigational Site | Metarie | Louisiana | 70006 | — |
| Novo Nordisk Investigational Site | Baltimore | Maryland | 21229 | — |
| Novo Nordisk Investigational Site | Minneapolis | Minnesota | 55416 | — |
| Novo Nordisk Investigational Site | Chesterfield | Missouri | 63017 | — |
| Novo Nordisk Investigational Site | City of Saint Peters | Missouri | 63376 | — |
| Novo Nordisk Investigational Site | Saint Charles | Missouri | 63303 | — |
| Novo Nordisk Investigational Site | Springfield | Missouri | 65807 | — |
| Novo Nordisk Investigational Site | St Louis | Missouri | 63110-1020 | — |
| Novo Nordisk Investigational Site | Billings | Montana | 59101 | — |
| Novo Nordisk Investigational Site | Butte | Montana | 59701 | — |
| Novo Nordisk Investigational Site | Lawrenceville | New Jersey | 08648 | — |
| Novo Nordisk Investigational Site | Albany | New York | 12206 | — |
| Novo Nordisk Investigational Site | Mineola | New York | 11501 | — |
| Novo Nordisk Investigational Site | New York | New York | 10029 | — |
| Novo Nordisk Investigational Site | New York | New York | 10032 | — |
| Novo Nordisk Investigational Site | Staten Island | New York | 10301 | — |
| Novo Nordisk Investigational Site | Syracuse | New York | 13210 | — |
| Novo Nordisk Investigational Site | Greensboro | North Carolina | 27408 | — |
| Novo Nordisk Investigational Site | Morehead City | North Carolina | 28557 | — |
| Novo Nordisk Investigational Site | Mentor | Ohio | 44060 | — |
| Novo Nordisk Investigational Site | Pittsburgh | Pennsylvania | 15224-2215 | — |
| Novo Nordisk Investigational Site | Upper Darby | Pennsylvania | 19082 | — |
| Novo Nordisk Investigational Site | Greer | South Carolina | 29651 | — |
| Novo Nordisk Investigational Site | Myrtle Beach | South Carolina | 29572 | — |
| Novo Nordisk Investigational Site | Summerville | South Carolina | 29485 | — |
| Novo Nordisk Investigational Site | Chattanooga | Tennessee | 37404-1192 | — |
| Novo Nordisk Investigational Site | Chattanooga | Tennessee | 37411 | — |
| Novo Nordisk Investigational Site | Memphis | Tennessee | 38119-3821 | — |
| Novo Nordisk Investigational Site | Nashville | Tennessee | 37203 | — |
| Novo Nordisk Investigational Site | Nashville | Tennessee | 37212 | — |
| Novo Nordisk Investigational Site | Amarillo | Texas | 79106 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75230 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75231 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75246 | — |
| Novo Nordisk Investigational Site | El Paso | Texas | 79912 | — |
| Novo Nordisk Investigational Site | Round Rock | Texas | 78681 | — |
| Novo Nordisk Investigational Site | Sugar Land | Texas | 77478 | — |
| Novo Nordisk Investigational Site | Salt Lake City | Utah | 84102 | — |
| Novo Nordisk Investigational Site | Bennington | Vermont | 05201 | — |
| Novo Nordisk Investigational Site | Norfolk | Virginia | 23510 | — |
| Novo Nordisk Investigational Site | Federal Way | Washington | 98003 | — |
| Novo Nordisk Investigational Site | Spokane | Washington | 99208 | — |
| Novo Nordisk Investigational Site | Milwaukee | Wisconsin | 53209 | — |
| Novo Nordisk Investigational Site | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 112 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01836523, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 6, 2017 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01836523 live on ClinicalTrials.gov.